Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 (hospitalized or not) meta-analysis

Rossi OBSanticoagulant, pre-admissioncontrolCOVID-19 (hospitalized or not)NA
-/- suggested
  • suggested 49 % decrease in deaths
Russo OBSanticoagulant, pre-admissioncontrolCOVID-19 (hospitalized or not)NA
-/- inconclusive
    Tremblay OBSanticoagulant, pre-admissioncontrolCOVID-19 (hospitalized or not)NA
    -/- inconclusive

      PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
      Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).